Items where Author is "Siccardi, Marco"
 | Up a level |
Article
Giardiello, Marco, Liptrott, Neill, McDonald, Tom, Moss, Darren, Siccardi, Marco, Martin, Phil, Smith, Darren, Gurjar, Rohan, Rannard, Steven and Owen, Andrew (2016) Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nature Communications, 7. p. 13184. ISSN 2041-1723
Siccardi, Marco, Martin, Phillip, Smith, Darren, Curley, Paul, McDonald, Tom, Giardiello, Marco, Liptrott, Neill, Rannard, Steven and Owen, Andrew (2016) Towards a rational design of solid drug nanoparticles with optimised pharmacological properties. Journal of Interdisciplinary Nanomedicine, 1 (3). pp. 110-123. ISSN 2058-3273
Martin, Philip, Giardiello, Marco, McDonald, Tom, Smith, Darren, Siccardi, Marco, Rannard, Steven and Owen, Andrew (2015) Augmented inhibition of CYP3A4 in human primary hepatocytes by ritonavir solid drug nanoparticles. Molecular Pharmaceutics, 12 (10). pp. 3556-3568. ISSN 1543-8384
McDonald, Tom, Giardiello, Marco, Martin, Philip, Siccardi, Marco, Liptrott, Neill, Smith, Darren, Roberts, Phill, Curley, Paul, Schipani, Alessandro, Khoo, Saye, Long, James, Foster, Alison, Rannard, Steven and Owen, Andrew (2014) Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro-In Vivo Correlation. Advanced Healthcare Materials, 3 (3). pp. 400-411. ISSN 21922640
Moss, Darren, Kwan, Wai San, Liptrott, Neill, Smith, Darren, Siccardi, Marco, Khoo, Saye, Back, David and Owen, Andrew (2011) Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir. Antimicrobial Agents and Chemotherapy, 55 (2). pp. 879-887. ISSN 0066-4804
Conference or Workshop Item
Martin, Philip, Liptrott, Neill, McDonald, Tom, Giardiello, Marco, Roberts, Phill, Curley, Paul, Smith, Darren, Siccardi, Marco, Rannard, Steven and Owen, Andrew (2013) Enhanced pharmacological properties of efavirenz formulated as solid drug nanoparticles. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, USA.
